UNITED CAPITAL FINANCIAL ADVISORS, LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1463217 IRVING, TX

Position in ALNY

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$1,250,779

-$101,817 QoQ

Shares Held

4,155

+1.6% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#376

of 784 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $15,880,894 across 17 Biotechnology names. ALNY ranks #3 (7.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	12,438	$6,178,327
2	REGN	Regeneron Pharmaceuticals, Inc.	2,651	$1,653,004
3	ALNY	Alnylam Pharmaceuticals, Inc. This page	4,155	$1,250,779
4	HALO	Halozyme Therapeutics, Inc.	13,677	$1,070,498
5	MRNA	Moderna, Inc.	13,077	$915,782
6	CBUS	Cibus, Inc.	576,043	$789,178
7	INCY	Incyte Corp	6,876	$779,463
8	IMMX	Immix Biopharma, Inc.	70,682	$728,731

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,250,779	4,155	+1.6%	Shares	Defined	2026-08-17
2026-03-31	$1,352,596	4,088	+66.9%	Shares	Defined	2026-05-15
2025-12-31	$973,844	2,449	+14.2%	Shares	Defined	2026-02-17
2025-09-30	$978,120	2,145	+36.2%	Shares	Defined	2025-11-14
2025-06-30	$513,591	1,575	+2.8%	Shares	Defined	2025-08-11
2025-03-31	$413,670	1,532	+3.5%	Shares	Defined	2025-05-13
2024-12-31	$348,258	1,480	-5.6%	Shares	Defined	2025-02-13
2024-09-30	$431,247	1,568	+3.2%	Shares	Defined	2024-11-12
2024-06-30	$369,360	1,520	+9.6%	Shares	Defined	2024-08-14
2021-06-30	$235,124	1,387	-6.7%	Shares	Defined	2021-08-13
2021-03-31	$209,949	1,487	-52.9%	Shares	Defined	2021-05-14
2020-12-31	$410,185	3,156	-91.2%	Shares	Defined	2021-02-17
2020-09-30	$5,200,249	35,716	+7.5%	Shares	Defined	2020-11-13
2020-06-30	$4,920,954	33,225	—	Shares	Defined	2020-08-13
No filing history on record for this holder in this stock.